BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10960525)

  • 1. Inactivation of WBCs in RBC suspensions by photoactive phenothiazine dyes: comparison of dimethylmethylene blue and MB.
    Skripchenko AA; Wagner SJ
    Transfusion; 2000 Aug; 40(8):968-75. PubMed ID: 10960525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of red cell properties after virucidal phototreatment with dimethylmethylene blue.
    Wagner SJ; Skripchenko A; Robinette D; Mallory DA; Cincotta L
    Transfusion; 1998 Aug; 38(8):729-37. PubMed ID: 9709780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting virus photoinactivation by a series of phenothiazine dyes.
    Wagner SJ; Skripchenko A; Robinette D; Foley JW; Cincotta L
    Photochem Photobiol; 1998 Mar; 67(3):343-9. PubMed ID: 9523534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a flow-cell system to investigate virucidal dimethylmethylene blue phototreatment in two RBC additive solutions.
    Wagner S; Skripchenko A; Thompson-Montgomery D
    Transfusion; 2002 Sep; 42(9):1200-5. PubMed ID: 12430679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus photoinactivation in stroma-free hemoglobin with methylene blue or 1,9-dimethylmethylene blue.
    Hirayama J; Wagner SJ; Gomez C; Macdonald VW; Abe H; Ikeda H; Ikebuchi K; Sekiguchi S
    Photochem Photobiol; 2000 Jan; 71(1):90-3. PubMed ID: 10649894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duck hepatitis B photoinactivation bydimethylmethylene blue in RBC suspensions.
    Wagner SJ; Skripchenko A; Pugh JC; Suchmann DB; Ijaz MK
    Transfusion; 2001 Sep; 41(9):1154-8. PubMed ID: 11552074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential sensitivities of viruses in red cell suspensions to methylene blue photosensitization.
    Wagner SJ; Robinette D; Storry J; Chen XY; Shumaker J; Benade L
    Transfusion; 1994 Jun; 34(6):521-6. PubMed ID: 8023394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of photosensitizing dyes for pathogen reduction in red cell suspensions.
    Wagner SJ; Skripchenko A
    Biotech Histochem; 2003; 78(3-4):171-7. PubMed ID: 14714880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of different antiviral treatments on the antioxidant systems of stroma-free hemoglobin.
    Hirayama J; Abe H; Kamo N; Ikebuchi K; Ikeda H
    Photochem Photobiol; 2001 Sep; 74(3):461-4. PubMed ID: 11594061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus inactivation in blood components by photoactive phenothiazine dyes.
    Wagner SJ
    Transfus Med Rev; 2002 Jan; 16(1):61-6. PubMed ID: 11788930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of methylene blue and methylene violet for photoinactivation of intracellular and extracellular virus in red cell suspensions.
    Skripchenko A; Robinette D; Wagner SJ
    Photochem Photobiol; 1997 Mar; 65(3):451-5. PubMed ID: 9077130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of dimethylmethylene blue for virus photoinactivation of red cell suspensions.
    Wagner SJ; Skripchenko A; Robinette D; Mallory DA; Hirayama J; Cincotta L; Foley J
    Dev Biol (Basel); 2000; 102():125-9. PubMed ID: 10794099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinacrine enhances vesicular stomatitis virus inactivation and diminishes hemolysis of dimethylmethylene blue-phototreated red cells.
    Wagner SJ; Skripchenko A; Thompson-Montgomery D
    Photochem Photobiol; 2002 Nov; 76(5):514-7. PubMed ID: 12462646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell alterations associated with virucidal methylene blue phototreatment.
    Wagner SJ; Storry JR; Mallory DA; Stromberg RR; Benade LE; Friedman LI
    Transfusion; 1993 Jan; 33(1):30-6. PubMed ID: 8380945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of reactive oxygen species in hemoglobin oxidation and virus inactivation by 1,9-dimethylmethylene blue phototreatment.
    Hirayama J; Wagner SJ; Abe H; Ikebuchi K; Ikeda H
    Biol Pharm Bull; 2001 Apr; 24(4):418-21. PubMed ID: 11305606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser-assisted optical rotational cell analyzer measurements reveal early changes in human RBC deformability induced by photodynamic treatment.
    Hardeman MR; Besselink GA; Ebbing I; de Korte D; Ince C; Verhoeven AJ
    Transfusion; 2003 Nov; 43(11):1533-7. PubMed ID: 14617311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel technique of antimicrobial photodynamic therapy - aPDT using 1,9-dimethyl-methylene blue zinc chloride double salt-DMMB and polarized light on Staphylococcus aureus.
    Santos DA; Crugeira PJL; Nunes IPF; de Almeida PF; Pinheiro ALB
    J Photochem Photobiol B; 2019 Nov; 200():111646. PubMed ID: 31655457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of both cell-free and cell-associated HIV infectivity in plasma by a filtration/methylene blue photoinactivation system.
    Abe H; Yamada-Ohnishi Y; Hirayama J; Owada T; Ikeda H; Ikebuchi K
    Transfusion; 2000 Sep; 40(9):1081-7. PubMed ID: 10988311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothermic storage of leukoreduced red blood cells for greater than 21 days is a safe alternative to irradiation.
    Mykhailova O; Turner TR; Olafson C; Howell A; Nahirniak SN; Wizniak J; Gerges HYN; Baldwin T; Clarke G; Acker JP
    Transfusion; 2021 Apr; 61(4):1247-1257. PubMed ID: 33481275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The band III ligand dipyridamole protects human RBCs during photodynamic treatment while extracellular virus inactivation is not affected.
    Besselink GA; Van Engelenburg FA; Korsten HG; Blokker DE; Lagerberg JW; Brand A; De Korte D; Verhoeven AJ
    Transfusion; 2002 Jun; 42(6):728-33. PubMed ID: 12147025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.